A novel dendrimer-based complex co-modified with cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment
Noninvasive drug delivery is a promising treatment strategy for ocular posterior segment diseases. Many physiological and anatomical barriers of the eye considerably restrict effective diffusion of therapeutics to the target site. To overcome this problem, a novel cyclic arginine-glycine-aspartate (...
Gardado en:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis Group
2019-01-01
|
| Series: | Drug Delivery |
| Assuntos: | |
| Acceso en liña: | http://dx.doi.org/10.1080/10717544.2019.1667455 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|